(Q37779717)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20706195%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

review article

1 reference

title

Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20706195%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20706195%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Cristiana Catena

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20706195%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author name string

Leonardo A Sechi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20706195%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Alessandro Di Fabio

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20706195%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

language of work or name

1 reference

12 August 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20706195%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Hypertension

10 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20706195%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20706195%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20706195%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

page(s)

1253-1260

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20706195%20AND%20SRC:MED&resulttype=core&format=json

Primary aldosteronism: renaissance of a syndrome

10 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

High rate of detection of primary aldosteronism, including surgically treatable forms, after ???non-selective??? screening of hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

CLINICAL CHARACTERISTICS OF PRIMARY ALDOSTERONISM FROM AN ANALYSIS OF 145 CASES.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Aldosterone as a cardiovascular risk factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Aldosterone in the development and progression of renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Primary aldosteronism: cardiovascular, renal and metabolic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Primary aldosteronism: an update on screening, diagnosis and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Primary aldosteronism: an update on screening, diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats: effects of eplerenone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Aldosterone and the vascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Mineralocorticoid receptor activation and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Exclusion of corticosterone from epithelial mineralocorticoid receptors is insufficient for selectivity of aldosterone action: in vivo binding studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Is aldosterone bad for the heart?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Aldosterone nongenomically produces NADPH oxidase-dependent reactive oxygen species and induces myocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Synergy of aldosterone and high salt induces vascular smooth muscle hypertrophy through up-regulation of NOX1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Cardiac specific increase in aldosterone production induces coronary dysfunction in aldosterone synthase-transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Reversible cardiac fibrosis and heart failure induced by conditional expression of an antisense mRNA of the mineralocorticoid receptor in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Antagonists of aldosterone and proteinuria in patients with CKD: an uncontrolled pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Cardiovascular outcomes in patients with primary aldosteronism after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Prevalence and characteristics of the metabolic syndrome in primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Adipokines and cardiometabolic profile in primary hyperaldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Echocardiographic comparison of left ventricular structure and function in hypertensive patients with primary aldosteronism and essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Inappropriate left ventricular mass in patients with primary aldosteronism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Changes in extracellular matrix in subcutaneous small resistance arteries of patients with primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Aldosterone-induced cardiac damage: focus on blood pressure independent effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Renal damage in primary aldosteronism: results of the PAPY Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Risk factors associated with a low glomerular filtration rate in primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Relative glomerular hyperfiltration in primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Rapid inhibition of vasoconstriction in renal afferent arterioles by aldosterone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Intrarenal hemodynamics in primary aldosteronism before and after treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

The dual role of the kidney in primary aldosteronism: key determinant in rescue from volume expansion and persistence of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

7 January 2021

Aldosterone and end-organ damage

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

7 January 2021

Aldosterone induces a vascular inflammatory phenotype in the rat heart

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

7 January 2021

Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

7 January 2021

Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

7 January 2021

Vascular complications in patients with aldosterone producing adenoma in Japan: comparative study with essential hypertension. The Research Committee of Disorders of Adrenal Hormones in Japan

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

7 January 2021

Cardiovascular complications in patients with primary aldosteronism

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

7 January 2021

Conn's syndrome and atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

7 January 2021

Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

7 January 2021

Insulin sensitivity in patients with primary aldosteronism: a follow-up study

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

7 January 2021

Changes in left ventricular anatomy and function in hypertension and primary aldosteronism

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

7 January 2021

Increased arterial wall stiffness in primary aldosteronism in comparison with essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

7 January 2021

Increased intima-media thickness of the common carotid artery in primary aldosteronism in comparison with essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

7 January 2021

Prevalence of extracranial carotid artery lesions at duplex in primary aldosteronism

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

7 January 2021

Vasodilation to acetylcholine in primary and secondary forms of human hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

7 January 2021

Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase in the human heart

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

7 January 2021

Mineralocorticoid receptors in myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

7 January 2021

Renal changes in primary aldosteronism

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

7 January 2021

Diagnosis and treatment of primary hyperaldosteronism.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

7 January 2021

Relationships of plasma renin levels with renal function in patients with primary aldosteronism

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

7 January 2021

Long-term renal outcomes in patients with primary aldosteronism

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

7 January 2021

Renal function curve in patients with secondary forms of hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.169

7 January 2021

Identifiers

DOI

10.1038/AJH.2010.169

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20706195%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference